| HGNC Family | Minor histocompatibility antigens |
| Name | thymidine phosphorylase |
| Description | This gene encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. It has a highly restricted target cell specificity acting only on endothelial cells. Mutations in this gene have been associated with mitochondrial neurogastrointestinal encephalomyopathy. Multiple alternatively spliced transcript variants have been identified. [provided by RefSeq, Apr 2012] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThymidine phosphorylase (TP), the protein product of the TYMP gene, is a key enzyme in pyrimidine nucleoside metabolism that catalyzes the reversible phosphorolysis of thymidine into thymine and 2‐deoxyribose‐1‐phosphate. This fundamental reaction is critical for normal nucleoside homeostasis and mitochondrial DNA maintenance. Inherited loss‐of‐function mutations in TYMP cause profound systemic accumulation of thymidine and deoxyuridine, which in turn disturb mitochondrial nucleotide pools and lead to multiple mitochondrial DNA deletions and depletion – a pathogenic mechanism underpinning disorders such as mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). In affected patients, efforts to restore TP activity (for example, via liver‐directed gene therapy) have been shown to normalize systemic nucleoside levels and prevent mtDNA damage."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA large body of evidence demonstrates that TP is frequently overexpressed in a wide variety of solid tumors – including cancers of the endometrium, oral cavity, lung, colon, prostate, and even cardiac myxoma – where its enzymatic activity is linked to enhanced angiogenesis, tumor invasion, and metastasis. The angiogenic effect is thought to be mediated largely by the generation of 2‐deoxyribose derivatives that stimulate endothelial cell migration, induce focal adhesion kinase phosphorylation, and trigger downstream pro‐survival and pro‐inflammatory signaling (for example, via PI3K/Akt). In addition, elevated TP expression is associated with cytoprotection against apoptotic stimuli, a finding that correlates with resistance to DNA damage and chemotherapeutic agents. Furthermore, studies have highlighted TP’s role in regulating the tumor microenvironment by modulating inflammatory cytokines and its interplay with other metabolic and transcriptional regulators."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its endogenous functions, TP plays a critical role in the bioactivation of several chemotherapeutic prodrugs. For instance, capecitabine requires TP to convert its intermediary metabolite into 5-fluorouracil, and high TP expression in tumors has been linked to better responses to such treatments. New therapeutic approaches and inhibitors (including noncompetitive inhibitors targeting allosteric sites) are under investigation to exploit TP’s dual role as both a facilitator of angiogenesis and a modulator of drug sensitivity. These findings have significant implications for prognostication and the development of combination regimens in cancers such as breast, ovarian, and gastric malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "32", "end_ref": "39"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its catalytic and proangiogenic functions, TP is subject to complex regulation at both the transcriptional and post‐transcriptional levels. Its expression can be modulated by inflammatory cytokines and stress‐responsive transcription factors such as Sp1 and hnRNP K, which in turn affect cellular resistance to hypoxia and DNA damage. Structural studies of TP have further elucidated details of its active‐site conformational dynamics and transition state, offering promising avenues for the design of potent inhibitors. Emerging data also suggest that targeting TP may have dual benefits – not only attenuating tumor angiogenesis and invasiveness but also interfering with the metabolic adaptations that confer chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "40", "end_ref": "43"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "J Gamez, C Ferreiro, M L Accarino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phenotypic variability in a Spanish family with MNGIE."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/wnl.59.3.455"}], "href": "https://doi.org/10.1212/wnl.59.3.455"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12177387"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12177387"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yutaka Nishigaki, Ramon Martí, William C Copeland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI17828"}], "href": "https://doi.org/10.1172/JCI17828"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12813027"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12813027"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "A Slama, C Lacroix, V Plante-Bordeneuve, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Metab (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymgme.2004.12.004"}], "href": "https://doi.org/10.1016/j.ymgme.2004.12.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15781193"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15781193"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "F J Carod-Artal, M D Herrero, M C Lara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Neurol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1468-1331.2007.01720.x"}], "href": "https://doi.org/10.1111/j.1468-1331.2007.01720.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17437622"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17437622"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "C Verny, P Amati-Bonneau, F Letournel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial DNA A3243G mutation involved in familial diabetes, chronic intestinal pseudo-obstruction and recurrent pancreatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.diabet.2008.06.001"}], "href": "https://doi.org/10.1016/j.diabet.2008.06.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18955007"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18955007"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jan-Willem Taanman, Mariza Daras, Juliane Albrecht, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2008.11.002"}], "href": "https://doi.org/10.1016/j.nmd.2008.11.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19056268"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19056268"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Zeren Bariş, Tuba Eminoğlu, Buket Dalgiç, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): case report with a new mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Pediatr (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00431-010-1237-0"}], "href": "https://doi.org/10.1007/s00431-010-1237-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20585803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20585803"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Javier Torres-Torronteras, Carlo Viscomi, Raquel Cabrera-Pérez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Ther (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mt.2014.6"}], "href": "https://doi.org/10.1038/mt.2014.6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24448160"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24448160"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Hiroshi Kojima, Noriharu Shijubo, Shosaku Abe "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cncr.10352"}], "href": "https://doi.org/10.1002/cncr.10352"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11920479"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11920479"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ritsuto Fujiwaki, Kohji Iida, Haruhiko Kanasaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/hupa.2002.31292"}], "href": "https://doi.org/10.1053/hupa.2002.31292"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11957147"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11957147"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "E Sivridis, A Giatromanolaki, I Papadopoulos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6600281"}], "href": "https://doi.org/10.1038/sj.bjc.6600281"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11986782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11986782"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Girolamo Ranieri, Angela Labriola, Gaetano Achille, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12429983"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12429983"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Geng Hui Zhu, Michelle Lenzi, Edward L Schwartz "}, {"type": "b", "children": [{"type": "t", "text": "The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1206030"}], "href": "https://doi.org/10.1038/sj.onc.1206030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12466967"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12466967"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Kylie A Hotchkiss, Anthony W Ashton, Edward L Schwartz "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M212670200"}], "href": "https://doi.org/10.1074/jbc.M212670200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12639965"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12639965"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Jun Sato, Makoto Sata, Hidenori Nakamura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.11315"}], "href": "https://doi.org/10.1002/ijc.11315"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12918063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12918063"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Wei Li, Kuniyoshi Tanaka, Akio Ihaya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Heart Circ Physiol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpheart.00176.2004"}], "href": "https://doi.org/10.1152/ajpheart.00176.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15374822"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15374822"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Wei Li, Kuniyoshi Tanaka, Koichi Morioka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine phosphorylase gene transfer inhibits vascular smooth muscle cell proliferation by upregulating heme oxygenase-1 and p27KIP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.ATV.0000168914.85107.64"}], "href": "https://doi.org/10.1161/01.ATV.0000168914.85107.64"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15879300"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15879300"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Hei-Cheul Jeung, Xiao-Fang Che, Misako Haraguchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protection against DNA damage-induced apoptosis by the angiogenic factor thymidine phosphorylase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2006.01.047"}], "href": "https://doi.org/10.1016/j.febslet.2006.01.047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16458893"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16458893"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Kamel El Omari, Annelies Bronckaers, Sandra Liekens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implications for drug design."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20060513"}], "href": "https://doi.org/10.1042/BJ20060513"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16803458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16803458"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Lih-Chyang Chen, Chuen Hsueh, Ngan-Ming Tsang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-08-0155"}], "href": "https://doi.org/10.1158/1078-0432.CCR-08-0155"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18559600"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18559600"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Eun Jeong Yu, Young Lee, Sun Young Rha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-08-0166"}], "href": "https://doi.org/10.1158/1541-7786.MCR-08-0166"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18922971"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18922971"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "L-C Chen, H-P Liu, H-P Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2009.55"}], "href": "https://doi.org/10.1038/onc.2009.55"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19330019"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19330019"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "I V Bijnsdorp, K Azijli, E E Jansen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Accumulation of thymidine-derived sugars in thymidine phosphorylase overexpressing cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Pharmacol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcp.2010.05.009"}], "href": "https://doi.org/10.1016/j.bcp.2010.05.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20488166"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20488166"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Phillip A Schwartz, Mathew J Vetticatt, Vern L Schramm "}, {"type": "b", "children": [{"type": "t", "text": "Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi101900b"}], "href": "https://doi.org/10.1021/bi101900b"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21222488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21222488"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "I V Bijnsdorp, F Capriotti, F A E Kruyt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2011.74"}], "href": "https://doi.org/10.1038/bjc.2011.74"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21386840"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21386840"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Tianshu Zhang, Naohiko Koide, Yuko Wada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ J (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1253/circj.67.54"}], "href": "https://doi.org/10.1253/circj.67.54"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12520153"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12520153"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Liu Huang, Shan Liu, Yu Lei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9923"}], "href": "https://doi.org/10.18632/oncotarget.9923"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27283904"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27283904"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Huan Liu, Zhiqiang Liu, Juan Du, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Transl Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scitranslmed.aad8949"}], "href": "https://doi.org/10.1126/scitranslmed.aad8949"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27559096"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27559096"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Xianglan Zhang, Zhenlong Zheng, You Keun Shin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathology (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAT.0000000000000094"}], "href": "https://doi.org/10.1097/PAT.0000000000000094"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24798152"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24798152"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Magdalena Tertil, Klaudia Skrzypek, Urszula Florczyk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0097070"}], "href": "https://doi.org/10.1371/journal.pone.0097070"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24819505"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24819505"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "J Scott Brockenbrough, Janice K Morihara, Stephen E Hawes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Histochem Cytochem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1369/jhc.2009.952804"}], "href": "https://doi.org/10.1369/jhc.2009.952804"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19654105"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19654105"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Ritsuto Fujiwaki, Kohkichi Hata, Kentaro Nakayama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.10319"}], "href": "https://doi.org/10.1002/ijc.10319"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11992400"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11992400"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "H Li, Z Suo, Y Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histol Histopathol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14670/HH-19.129"}], "href": "https://doi.org/10.14670/HH-19.129"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14702180"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14702180"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Tomohiro Emura, Fumio Nakagawa, Akio Fujioka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2004)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14719072"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14719072"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Sandra Liekens, Ana-Isabel Hernández, Domenico Ribatti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M402602200"}], "href": "https://doi.org/10.1074/jbc.M402602200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15123637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15123637"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Dong Hua, Zhao-Hui Huang, Yong Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.v13.i37.5030"}], "href": "https://doi.org/10.3748/wjg.v13.i37.5030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17854149"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17854149"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "C Andreetta, C Puppin, A Minisini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdn592"}], "href": "https://doi.org/10.1093/annonc/mdn592"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18765464"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18765464"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Michal Stark, Eran E Bram, Martin Akerman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.163444"}], "href": "https://doi.org/10.1074/jbc.M110.163444"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21068389"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21068389"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Jing Gao, Ming Lu, Jing-Wei Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-11-177"}], "href": "https://doi.org/10.1186/1471-2407-11-177"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21586171"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21586171"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Xian-Hua Wu, Cheng Qian, Kai Yuan "}, {"type": "b", "children": [{"type": "t", "text": "Correlations of hypoxia-inducible factor-1α/hypoxia-inducible factor-2α expression with angiogenesis factors expression and prognosis in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Chin Med J (Engl) (2011)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21362301"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21362301"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Chi-Sheng Wu, Kai-Ping Chang, Lih-Chyang Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oral Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.oraloncology.2012.01.005"}], "href": "https://doi.org/10.1016/j.oraloncology.2012.01.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22321252"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22321252"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Ryosuke Tamura, Yoshihito Yokoyama, Hidemi Yoshida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Ovarian Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13048-014-0094-2"}], "href": "https://doi.org/10.1186/s13048-014-0094-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25304388"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25304388"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Huijuan Liu, Yuan Qin, Denghui Zhai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antimalarial Drug Pyrimethamine Plays a Dual Role in Antitumor Proliferation and Metastasis through Targeting DHFR and TP."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-18-0936"}], "href": "https://doi.org/10.1158/1535-7163.MCT-18-0936"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30642883"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30642883"}]}]}]}
|
| Synonyms | ECGF, ECGF1, MNGIE, MEDPS1, HPD-ECGF, PDECGF, MTDPS1, TP |
| Proteins | TYPH_HUMAN |
| NCBI Gene ID | 1890 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TYMP has 7,522 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 110 datasets.
Click the + buttons to view associations for TYMP from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TYMP gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of TYMP gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TYMP gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TYMP gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TYMP gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of TYMP gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TYMP gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TYMP gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TYMP gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TYMP gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with TYMP protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with TYMP gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TYMP gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TYMP gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TYMP gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of TYMP gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TYMP gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TYMP protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TYMP protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TYMP gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TYMP gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with TYMP gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with TYMP gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of TYMP protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TYMP gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for TYMP protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving TYMP gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving TYMP gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with TYMP gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TYMP gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TYMP gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TYMP gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with TYMP gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for TYMP protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TYMP gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TYMP gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TYMP gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TYMP from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TYMP gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with TYMP gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TYMP from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TYMP gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TYMP gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TYMP gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TYMP gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TYMP gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TYMP gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TYMP gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TYMP gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TYMP protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TYMP gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by TYMP gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TYMP gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TYMP gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TYMP gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with TYMP gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with TYMP gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with TYMP gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for TYMP protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TYMP gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TYMP gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of TYMP protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TYMP gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of TYMP protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with TYMP gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for TYMP from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with TYMP gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with TYMP gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TYMP gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| HumanCyc Pathways | pathways involving TYMP protein from the HumanCyc Pathways dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TYMP protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TYMP gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TYMP gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TYMP gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TYMP gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TYMP gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TYMP gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of TYMP gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TYMP gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing TYMP protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TYMP protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TYMP gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting TYMP gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TYMP gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by TYMP gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for TYMP from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TYMP gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for TYMP protein from the MW Gene Metabolite Associations dataset. | |
| NURSA Protein Complexes | protein complexs containing TYMP protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with TYMP gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TYMP from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TYMP gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TYMP gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TYMP protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TYMP protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving TYMP protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving TYMP protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TYMP gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TYMP gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TYMP gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of TYMP gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TYMP gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TYMP gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with TYMP protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TYMP gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TYMP protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of TYMP protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TYMP protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| WikiPathways Pathways 2014 | pathways involving TYMP protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving TYMP protein from the WikiPathways Pathways 2024 dataset. | |